10-KPeriod: FY2017

CENTENE CORP Annual Report, Year Ended Dec 31, 2017

Filed February 20, 2018For Securities:CNC

Summary

Centene Corporation, a diversified healthcare enterprise, reported strong financial performance for the year ended December 31, 2017. The company experienced significant growth in total revenues, reaching $48.4 billion, a 19% increase year-over-year, driven largely by the full-year impact of the Health Net acquisition and organic membership growth across its government-sponsored and commercial healthcare programs. Net earnings from continuing operations attributable to Centene were $828 million, a substantial increase of 48% compared to the prior year, reflecting improved operational efficiencies and strategic execution. The company's membership grew by 7% to 12.2 million, underscoring its expanding reach in serving under-insured and uninsured individuals through Medicaid, Medicare, and Health Insurance Marketplace offerings. Centene also announced a significant strategic move with an agreement to acquire Fidelis Care in New York for $3.75 billion, signaling a continued commitment to expanding its market presence. The company's robust financial performance and strategic growth initiatives position it for continued success in the healthcare sector.

Financial Statements
Beta
Revenue$48.38B
Cost of Revenue$1.85B
Gross Profit$46.53B
SG&A Expenses$4.45B
Operating Expenses$47.18B
Operating Income$1.20B
Interest Expense$255.00M
Net Income$828.00M
EPS (Basic)$2.40
EPS (Diluted)$2.34
Shares Outstanding (Basic)344.85M
Shares Outstanding (Diluted)353.40M

Key Highlights

  • 1Total revenues increased by 19% to $48.4 billion in 2017.
  • 2Net earnings from continuing operations grew by 48% to $828 million in 2017.
  • 3Total membership reached 12.2 million, a 7% increase year-over-year.
  • 4The company signed an agreement to acquire Fidelis Care for $3.75 billion, expanding its New York presence.
  • 5Health Benefits Ratio (HBR) was 87.3%, with SG&A expense ratio at 9.7%.
  • 6Diluted EPS increased by 38% to $4.69 in 2017.

Frequently Asked Questions

Centene reported a significant increase in total revenues, reaching $48.4 billion in 2017, which represents a 19% growth compared to the prior year. This growth was primarily attributed to the full year impact of the Health Net acquisition and organic membership expansion.

Centene demonstrated strong profitability in 2017, with net earnings from continuing operations attributable to Centene increasing by 48% to $828 million. Diluted EPS also saw substantial growth, rising 38% to $4.69.

Centene's strategy focuses on increasing penetration in existing state markets, diversifying its business lines, addressing emerging state needs, developing and acquiring additional markets, leveraging its established infrastructure for efficiency, and maintaining operational discipline. A major strategic development in 2017 was the agreement to acquire Fidelis Care for $3.75 billion, which is expected to enhance its market position in New York.

Centene's total membership grew by 7% to 12.2 million as of December 31, 2017. This growth reflects the company's success in expanding its reach across its various government-sponsored and commercial healthcare programs.